Roxbury Christopher R, Smith David F, Higgins Thomas S, Lee Stella E, Gallia Gary L, Ishii Masaru, Lane Andrew P, Reh Douglas D
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Am J Rhinol Allergy. 2017 Mar 1;31(2):109-116. doi: 10.2500/ajra.2017.31.4420.
Acute invasive fungal rhinosinusitis (AIFR) is a fulminant fungal infection seen in patients who are immunocompromised. Due to its rarity, there is little evidence regarding the appropriate antifungal treatment regimen, especially the degree of surgical intervention.
To assess factors that impact short-term survival in AIFR as defined by survival to hospital discharge and to develop a staging system to predict survival and complete surgical resection.
Fifty-four patients with histopathologically diagnosed AIFR who met inclusion criteria were identified between 1984 and 2014. Patient characteristics, disease extent, treatment modality, and short-term survival data were collected. Univariate analysis was performed to assess for factors associated with survival and increased likelihood of surgical resection.
Of 52 patients with adequate documentation, 36 (69.2%) survived their hospital stay. Complete surgical resection was the only factor associated with improved survival (survival, 95.5%; p < 0.01). A surgical staging system was proposed to guide probability of complete resection and overall prognosis, with stage I disease limited to the nasal cavity, stage II involving the paranasal sinuses, stage III involving the orbit, and stage IV with skull base or intracranial extension. The χ2 analyses showed a decreased likelihood of complete surgical resection with stage III or IV disease compared with stage I (resection, 90.9%) (stage III resection, 37.5% [p = 0.01]; stage IV resection, 16.7% [p = 0.002]). There was a decreased likelihood of survival associated with increasing disease stage compared with stage I (survival, 100%) (stage II survival, 60% [p = 0.009]; stage III survival, 62.5% [p = 0.02]; stage IV survival, 54.6%, [p = 0.006]).
Although further studies are needed to define specific treatment protocols, analysis of these data indicated that endoscopic sinus surgery with the goal of complete surgical resection may provide the best survival outcomes in select patients when complete surgical resection can be performed. Our staging system represents the first attempt to predict surgical success and prognosis in patients with AIFR.
急性侵袭性真菌性鼻-鼻窦炎(AIFR)是一种在免疫功能低下患者中出现的暴发性真菌感染。由于其罕见性,关于合适的抗真菌治疗方案,尤其是手术干预程度的证据很少。
评估影响AIFR患者短期生存(定义为存活至出院)的因素,并开发一种分期系统以预测生存和完全手术切除情况。
在1984年至2014年间确定了54例经组织病理学诊断为AIFR且符合纳入标准的患者。收集患者特征、疾病范围、治疗方式和短期生存数据。进行单因素分析以评估与生存及手术切除可能性增加相关的因素。
在52例有充分记录的患者中,36例(69.2%)存活至出院。完全手术切除是与生存改善相关的唯一因素(生存率95.5%;p<0.01)。提出了一种手术分期系统以指导完全切除的可能性和总体预后,I期疾病局限于鼻腔,II期累及鼻窦,III期累及眼眶,IV期伴有颅底或颅内扩展。χ2分析显示,与I期相比,III期或IV期疾病完全手术切除的可能性降低(I期切除率90.9%)(III期切除率37.5%[p = 0.01];IV期切除率16.7%[p = 0.002])。与I期相比,随着疾病分期增加,生存可能性降低(I期生存率100%)(II期生存率60%[p = 0.009];III期生存率62.5%[p = 0.02];IV期生存率54.6%,[p = 0.006])。
尽管需要进一步研究来确定具体的治疗方案,但对这些数据的分析表明,在能够进行完全手术切除的特定患者中,如果以完全手术切除为目标,内镜鼻窦手术可能提供最佳生存结果。我们的分期系统是首次尝试预测AIFR患者的手术成功率和预后。